Orbis Investment Management (US)’s Amgen AMGN Stock Holding History

Orbis Investment Management (US)’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-13,897	Closed	-$2.08M	–	25
2016 Q1	$2.08M	Sell	13,897 -15,989	-53%	-$2.38M	1.8%	21
2015 Q4	$4.85M	Sell	29,886 -4,150	-12%	-$652K	4.17%	12
2015 Q3	$4.71M	Sell	34,036 -13,626	-29%	-$2.15M	4.27%	11
2015 Q2	$7.32M	Sell	47,662 -7,514	-14%	-$1.2M	5.9%	5
2015 Q1	$8.82M	Sell	55,176 -2,474	-4%	-$390K	7.25%	4
2014 Q4	$9.18M	Sell	57,650 -5,428	-9%	-$846K	7.61%	3
2014 Q3	$8.86M	Hold	63,078	–	–	7.36%	4
2014 Q2	$7.47M	Buy	63,078 +15,728	+33%	+$1.82M	6.19%	5
2014 Q1	$5.84M	Buy	+47,350	New	+$5.74M	5.31%	5

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Orbis Investment Management (US)'s AMGN Position: Q2 2016 in Review

Orbis Investment Management (US) sold out of Amgen (AMGN) in Q2 2016, closing a stake of 13,897 shares — an estimated $2.08M sold.

Orbis Investment Management (US) first reported a position in AMGN in Q1 2014 and held it in 9 quarters. The position peaked at $9.18M in Q4 2014. 1,473 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

Orbis Investment Management (US) reported no remaining Amgen position as of Q2 2016 after selling out during the quarter.
Orbis Investment Management (US) sold 13,897 Amgen shares in Q2 2016, an estimated $2.08M.
Orbis Investment Management (US) first reported a position in Amgen in Q1 2014 and held it in 9 quarters.
Orbis Investment Management (US)'s Amgen position peaked at $9.18M in Q4 2014.
1,473 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on Orbis Investment Management (US)'s 13F filing for Q2 2016, filed 15 Aug 2016.